Last Price
381.47
Today's Change
+0.97 (0.25%)
Day's Change
373.99 - 385.69
Trading Volume
392,734
Market Cap
11 Billion
Shares Outstanding
31 Million
Avg Volume
234,708
Avg Price (50 Days)
404.57
Avg Price (200 Days)
348.30
PE Ratio
35.89
EPS
10.63
Earnings Announcement
21-Oct-2024
Previous Close
380.50
Open
381.59
Day's Range
373.99 - 385.695
Year Range
227.21 - 459.77
Trading Volume
392,734
1 Day Change
0.25%
5 Day Change
-9.59%
1 Month Change
-5.89%
3 Month Change
-3.65%
6 Month Change
27.94%
Ytd Change
24.83%
1 Year Change
48.71%
3 Year Change
110.26%
5 Year Change
498.29%
10 Year Change
1272.69%
Max Change
1272.69%
No result.
Sector: Healthcare - Healthcare
Industry: Diagnostics & Research
Description:
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.